IB COMMUNICATIONS PRESS RELEASES

Bristol and London, UK, 26 November 2025 - eXmoor Pharma, the integrated cell and gene therapy CDMO with embedded consultancy expertise, and Royal Free London NHS Foundation Trust, through its Cell and Vector Innovation Centre (CVIC), have entered a strategic collaboration to build a seamless.....

Lakewood, Colorado — November 18, 2025 — Terumo Blood and Cell Technologies (Terumo BCT), a global leader in cell and gene therapy technologies, today announced an advancement in T cell therapy manufacturing in a collaboration with Richard Koya, M.D., Ph.D., and his team at University of Chicago....

Wyoming, US, 13 Nov 2025 — IB Communications and its independent broadcast division, IBTV, are excited to participate in Advanced Therapies 2025, taking place in Philadelphia from 18–19 November 2025. IB Communications will manage the event’s press and media room, while IBTV delivers video

LAKEWOOD, Colo., USA - November 13, 2025 – Terumo Blood and Cell Technologies (Terumo BCT) a medical technology company, today announced the appointment of Liza Loidolt as General Manager of the company’s Cell and Gene Therapy (CGT) business. This leadership appointment strengthens Terumo.....

LAKEWOOD, Colo., USA and Zurich, Switzerland - November 12, 2025 – Terumo Blood and Cell Technologies (Terumo BCT) and Santersus AG today announced an exclusive partnership to advance a novel technology to improve clinical outcomes for patients who become critically ill due to sepsis. The.....

St. Paul, MN, November 3rd, 2025 – ScaleReady, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation and CellReady, today announced that Sonoma Biotherapeutics has been awarded a $300,000 G-Rex® Grant.  SonomaBio’s G-Rex® Grant will enable expeditious development of a.....

Wyoming, US, 24 Oct 2025 — IBTV, the independent broadcast division of IB Communications, is proud to announce its partnership with AABB to deliver video coverage and creative media production at the 2025 AABB Annual Meeting. This collaboration will bring the meeting’s most compelling conversations

ST. PAUL, Minn., Oct. 23, 2025 - ScaleReady, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation (NASDAQ: TECH) and CellReady, announced four G-Rex Grants have been awarded to faculty members at Children's National Hospital. The funding, totaling $375,000, will support the.....

LAKEWOOD, Colo., USA - October 22, 2025 – To help address platelet shortages and streamline blood center operations, The Blood Center in New Orleans has become the second U.S. blood center to implement the Reveos™ Automated Blood Processing System and the Lumia™ Software Platform from.....

LAKEWOOD, Colo., USA - October 9, 2025 – Millions of people living with sickle cell disease and other hemoglobin (Hb) disorders face delayed diagnosis and limited access to care, especially in regions where testing is scarce [1]. To help address these challenges, Terumo Blood and Cell Technologies.....

Tel Aviv, London, and Pittsburgh, October 6, 2025 — Adva Biotechnology Ltd. and Autolomous Ltd. today announced the launch of the Digital PIONEER Program, a joint initiative aimed at digitizing, decentralizing, and scaling out autologous cell therapy manufacturing. GenCART Inc., a promising.....

Kansas City, MO – October 1, 2025 – Likarda, a global leader in complex therapy formulation for cell and large-molecule therapeutics, today announced the launch of Predictive Polymer Analytics (PPA)™, its next-generation artificial intelligence.....

SCOTTSDALE, Ariz., USA - September 30, 2025 — Vitalant, one of the nation’s largest nonprofit blood and biotherapies healthcare organizations, today announces the launch of its national hub-and-spoke model for cell and gene therapy, anchored by customized service hubs in Phoenix, Denver, and...

Rome, Italy – 09.30.2025 – ReiThera Srl, the Italian leading Contract Development and Manufacturing Organization (CDMO) specialized in the development and GMP manufacturing of viral vectors for gene therapies and vaccines, today announced its participation at the European Society of.....

LAKEWOOD, Colo., USA - September 30, 2025 – In a landmark move, the Ministries of Health of Kenya and Côte d’Ivoire, together with Uganda’s Joint Clinical Research Centre (JCRC) under the stewardship of the Uganda Ministry of Health, have signed three Memoranda of Understanding (MoUs).....

Bristol, UK and Bangkok, Thailand, 23rd September - eXmoor Pharma, the integrated cell and gene therapy CDMO with embedded consultancy expertise, and Siam Bioscience, a leading biopharmaceutical company in ASEAN, today announced a strategic partnership to build the region’s

BOCA RATON, Fla. and LAKEWOOD, Colo., USA - September 18, 2025 – CSL Plasma and Terumo Blood and Cell Technologies (Terumo BCT) today announced that the Rika™ Plasma Donation System has been deployed in all CSL Plasma centers across the U.S. — a major milestone in donor care, operational

LAKEWOOD, Colo., USA - September 16, 2025 – In a significant step toward expanding treatment access for people with rare and chronic diseases in Latin America (LATAM), Terumo Blood and Cell Technologies (Terumo BCT), a global medical technology company, today announced.....

Mulhouse, France, September 10, 2025 – CellProthera today announced that its open-label randomized controlled EXCELLENT Phase I/IIb trial results have been published in JACC: Heart Failure, delivering the first peer-reviewed data on ProtheraCytes® in patients suffering from a large myocardial infarction (MI). 

Phoenix, AZ, September 9, 2025 – Title21 Health Solutions, the software innovators for meeting life science regulatory needs, announces the outcomes of its inaugural Advisory Council meeting, where industry leaders identified interoperability and cross-sector collaboration as two of the most pressing.....

ST. PAUL, Minn., Sept. 9, 2025 - ScaleReady, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation (NASDAQ: TECH) and CellReady, today announced that eight (8) G-Rex Grants, totaling nearly $2 million in support, have been awarded to awardees of the California Institute for

Brussels, Belgium - September 2, 2025 – Terumo Blood and Cell Technologies, (Terumo BCT), a medical technology company, and PwC Belgium today announce a new collaboration focused on driving equitable and sustainable access to Advanced Therapy Medicinal Products (ATMPs). As part of the bold.....

Bristol and London, UK, 2nd September 2025 - eXmoor Pharma, the integrated cell and gene therapy CDMO with embedded consultancy expertise, has announced a new strategic partnership with Anthony Nolan: Cell Therapy & Laboratory Services (CT&LS), the experts in cellular starting materials.....

PITTSBURGH, Aug. 26, 2025 — Vitalant, a leading national blood and biotherapies services provider, is deepening its partnership with UPMC, a world-renowned healthcare organization, to support and enhance the health system’s cell and gene therapy initiatives through medical leadership and laboratory operations.

Tel Aviv and London, August 25, 2025 — Adva Biotechnology Ltd. and Autolomous Ltd. have announced a strategic collaboration to co-lead the Digital Pioneer Program, an early adopter initiative focused on digitising, decentralising, and scaling out autologous cell therapy manufacturing.

ST. PAUL, Minn., Aug. 5, 2025 - ScaleReady, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation and CellReady, today announced that Sidra Medicine, a women and children's hospital in Qatar, has been awarded a $100,000 G-Rex® Grant. Sidra Medicine's G-Rex® Grant will enable.....

Harare, Zimbabwe; Rome, Italy; New York, NY, and Cambridge, MA, USA, August 4, 2025 – The Mutala Trust, ReiThera Srl (ReiThera), the Ragon Institute of Mass General Brigham, MIT, and Harvard (the Ragon Institute), and IAVI are pleased to announce that the first doses of an .....

Rome, Italy, August 4, 2025 - ReiThera Srl, a biotechnology company specialized in viral vector development and GMP manufacturing, is proud to support the launch of a Phase 1 clinical trial in Africa of the HIV vaccine candidate GRAdHIVNE1. The vaccine, designed to induce potent T cell responses against.....

ST. PAUL, Minn., July 31, 2025 - ScaleReady, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation (NASDAQ: TECH) and CellReady, today announced that three investigators at the University of Minnesota's Center for Genome Engineering have been awarded $665,000 of G-Rex® Grant funding.

Barcelona, Spain and Düsseldorf, Germany, 23 July 2025 – Minoryx Therapeutics, a late-stage biotech company focused on the development of therapies for orphan central nervous system (CNS) disorders and Neuraxpharm Group (Neuraxpharm), a leading European specialty pharmaceutical .....

San Sebastián, Gipuzkoa, Spain, July 3, 2025 – VIVEbiotech, a leading Contract Development and Manufacturing Organization (CDMO) specializing in lentiviral vector (LVV) development and manufacturing for in vivo and ex vivo gene and cell therapies, today announced the appointment of...

Mulhouse, France, June 22, 2025 – CellProthera, a regenerative cell therapy developer specializing in ischemic diseases, announces the presentation today of new clinical data by collaborators from Université Paris Cité, demonstrating improvements in health-related quality of life (HRQoL) for patients

Lakewood, Colorado, June 18, 2025 – Terumo Blood and Cell Technologies, (Terumo BCT), a medical technology company, published a new protocol in a paper demonstrating expanded capabilities for its Quantum™ system to unlock rapid CAR-T cell expansion. The protocol consolidates the processes of T cell

LONDON, UK & WYOMING, US, June 18, 2025 — Advanced Therapies Think Tank (AT3) has unveiled its Season One Faculty ahead of the inaugural episode launching on July 3. With legendary names like Carl June alongside rising voices like Nicole Paulk and Anji Miller, this think tank has been...

Bristol, UK and Paris, France —  17 June 2025: eXmoor Pharma, the integrated cell and gene therapy CDMO with embedded consultancy expertise, and Signadori Bio, a French biotechnology company developing next-generation cancer therapies, today announced a new collaboration to...

June 17, 2025 - At the BIO International Convention 2025 in Boston, King Faisal Specialist Hospital & Research Centre (KFSHRC) and Germfree Laboratories, LLC announced a strategic partnership to develop Saudi Arabia’s first fully integrated, modular Advanced Therapy Medicinal Product (ATMP) Manufacturing Campus.

St. Paul, MN (June 10, 2025) – ScaleReady, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation and CellReady, today announced that Immuneel Therapeutics has been awarded a $150,000 G-Rex® Grant to support process development aimed at enhancing the scalability...

MADISON, WI and KANSAS CITY, MO, June 9, 2025 - Axio BioPharma Inc., a next-generation biomanufacturing company using AI to transform mammalian protein production, and Likarda Inc., a leader in advanced drug delivery and formulation technologies, today announced a strategic partnership...

Mulhouse, France, May 20, 2025 – CellProthera, a regenerative cell therapy developer specializing in ischemic diseases, has chosen CELLforCURE by SEQENS, as its contract development and manufacturing organization (CDMO) partner for its planned Phase 3 trial for ProtheraCytes®, its autologous expanded...

Huddinge, Sweden, May 20, 2025 – NextCell Pharma AB ("NextCell" or "the Company") has entered into a strategic collaboration with Fujifilm Irvine Scientific Inc. to bring together their core competences in mesenchymal stromal cells (MSCs) and raw materials for the life science sector. The aim of the...

ST. PAUL, Minn., May 14, 2025 - ScaleReady, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation (NASDAQ: TECH) and CellReady announced today three G-Rex Grants that have been awarded to faculty members at the University of Southern California (USC) and the Children's Hospital of...

Bristol, UK and Leuven, Belgium — 13 May 2025 - eXmoor Pharma, the integrated cell and gene therapy CDMO with embedded consultancy expertise, has entered into a strategic partnership with KU Leuven, one of Europe’s leading academic institutions, to support a new cell and gene therapy hub. The...

Rome, Italy - May 12 2025 – ReiThera, the Italian CDMO company specialized in the development and manufacturing of genetic vaccines and advanced therapies, is pleased to announce its participation in the 27th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT), taking place May 13–17, 2025, in New Orleans, LA.

Lakewood, Colorado, May 12, 2025 – Terumo Blood and Cell Technologies, (Terumo BCT), a medical technology company, announces that Join Parachute will be adopting the Rika™ Plasma Donation System, a next-generation plasma collection system engineered to streamline plasma collection and prioritize donor comfort. 

Huddinge, Sweden, May 8, 2025 – NextCell Pharma AB (“NextCell” or the “Company”), the Scandinavian leader in mesenchymal stromal cell (MSC) therapies, announces its Chief Scientific Officer (CSO), Dr Lindsay Davies, has been named to the Board of Advisors of Advanced Therapies Europe, and...

Washington, DC and Wyoming, MAY 7, 2025 – America’s Blood Centers (ABC), the national organization of community-based, independent blood centers that supply 60 percent of the nation’s blood supply, today announced that it has joined the Blood and Cells Advocacy Roster (BCAR). BCAR is an...

Phoenix, AZ, May 6, 2025 – Title21 Health Solutions, the software innovators for meeting life science regulatory needs, has named its inaugural Advisory Committee featuring five leaders from the cell and gene therapy (CGT) space, who bring a breadth of leadership, clinical, and entrepreneurial experience to support the company’s growth.

Mulhouse, France, April 30, 2025 – CellProthera, a regenerative cell therapy developer specializing in ischemic diseases, will be presenting two oral abstracts at International Society for Cell & Gene Therapy (ISCT) 2025 New Orleans on May 8 stemming from the recently completed Phase 1/2b EXCELLENT trial for the company’s lead therapy...

Kansas City, MO, April 22, 2025 – Likarda, a leading biotech company specializing in the development of enabling technologies for the delivery of both cell therapies and large molecule biologics, announced a new peer-reviewed publication that demonstrates a promising improvement in the effort to develop liver cell-based therapies for patients with....

LAKEWOOD, Colorado, — April 16, 2025 — Terumo Blood and Cell Technologies (Terumo BCT), a medical technology company, today announced the addition of Patrick Daly as its Chief Business Officer as the company continues to expand its capabilities to meet evolving market segments. Daly joins Terumo BCT with over 30 years of business and healthcare industry experience....

London, UK, April 7, 2025 – Phacilitate is pleased to announce that registration is now open for Advanced Therapies Europe 2025, 2–4 September at the Hotel Arts, Ritz-Carlton, in Barcelona, one of Europe’s fastest-growing biotech hubs. This exclusive gathering brings together 500 pre-approved leaders from across the advanced therapies ecosystem for three days of high-impact content, curated networking and strategic deal-making.

Phoenix, AZ, April 2, 2025 – Title21 Health Solutions, the software innovators for meeting life science regulatory needs, announced the addition of Jonathan Wofford as the company’s first Chief Commercial Officer (CCO) to oversee the company’s products, sales, and marketing efforts. Wofford has over two decades of experience in the cell therapy and stem....

Mulhouse, France, March 27, 2025 – CellProthera, a regenerative cell therapy developer specializing in ischemic diseases, named its new Board of Directors led by co-founder Jérôme Koch, in line with recent bridge financing organized among shareholders and new investors. The new board features both investors and independent members, with a wealth....

Lakewood, Colorado, March 18, 2025 – Terumo Blood and Cell Technologies, (Terumo BCT), a medical technology company, signed a memorandum of understanding (MOU) with Osong Medical Innovation Foundation (KBIOHealth) toward joint development of workforce training for cell and gene therapy (CGT) manufacturing. The partners will begin

London, UK; March 14, 2025 - IB Communications, an international media relations and public strategy firm, and Terrapinn, a global company whose events promote innovation and technology that changes people’s lives, today announce a partnership to increase audience reach of the life sciences community for the content for Advanced Therapies UK 2025....

Kansas City, MO, March 12, 2025 – Likarda, a leading biotech company specializing in the development of enabling technologies for the delivery of both cell therapies and large molecule biologics, announced a new grant from the Gates Foundation that supports the company’s proprietary Core-Shell Spherification® (CSS®) system to extend th....

Rome, Italy – March 12 2025 – ReiThera, a global Contract Development and Manufacturing Organization (CDMO), is highlighting its latest vector platform, ReiCell-AAV, alongside the rest of its comprehensive portfolio at Advanced Therapies 2025 in London. ReiCell-AAV enables scalable production of AAVs, the most common vector used in commercial....

Mulhouse, France, March 11, 2025 – CellProthera, a regenerative cell therapy developer specializing in ischemic diseases, announced it will be presenting next week at Terrapinn’s Advanced Therapies Congress 2025, held in London. Ibon Garitaonandia, PhD, MBA, Chief Scientific Officer, will present on “Development of cell-based therapies for Post-acute .....

Barcelona, Spain – 5 March 2025 – Minoryx Therapeutics, a late-stage biotech company focused on the development of therapies for orphan central nervous system (CNS) disorders, today announces that the first patient in the TREE study has been dosed with leriglitazone. TREE is a phase 2a clinical study assessing the safety and efficacy of lead candidate leriglitazone, a novel, brain-penetrant and selective PPAR gamma agonist, to treat patients with Rett syndrome.

Chicago, IL, February 26, 2025 – Pragmatrix Technology (“Pragmatrix”), a pioneer in SaaS solutions for the cell therapy industry, proudly announces its partnership with Achieve Clinics (“Achieve”), a Los Angeles, California biotechnology company dedicated to improving patient access to autologous cell therapies. A customized version of PragLife, Pragmatrix’s flagship platform, will now be implemented to support Achieve Clinics' operations end-to-end.

Lakewood, Colorado, February 25, 2025 – Terumo Blood and Cell Technologies (Terumo BCT), a medical technology company, announced a partnership with the nonprofit National Alliance of Sickle Cell Centers (NASCC) that aims to improve the lives of people with sickle cell disease (SCD) by addressing gaps in access to blood transfusion therapy and helping....

Bürkert Fluid Control Systems has taken a stake in Green Elephant Biotech as a strategic investor so the two companies can work together to develop more efficient, flexible and sustainable cell cultivation processes in the pharmaceutical and....

Lakewood, Colorado, January 29, 2025 – Terumo Blood and Cell Technologies, a global leader in blood management solutions, today announces that Carter BloodCare is the first U.S. adopter of its Reveos™ Automated Blood Processing System and Lumia™ Software Platform. Carter BloodCare, one of the largest Texas blood centers, is the first to begin....

Rome, Italy January 24th 2025 – ReiThera is proud to announce a new partnership with SillaJen through a comprehensive Master Service Agreement (MSA), which establishes ReiThera as the manufacturing partner for SillaJen’s innovative anticancer virus platform, the SJ-600 series.....

London, UK, January 22, 2025 – Phacilitate, a leading brand that connects advanced therapies industry leaders through inspiring conferences, vibrant communities and market intelligence, today presented Katherine A. High, M.D. with its prestigious Lifetime Achievement Award for 2025. Dr. High, who is now President of Therapeutics at AskBio, has had....

Lakewood, Colorado, January 21, 2025 – Terumo Blood and Cell Technologies (Terumo BCT), a medical technology company, believes the future of medicine begins with a single drop of blood. From lifesaving blood transfusions to novel personalized therapies, blood and cells are the foundation of healthcare innovation......

January 21 2025 – SOMERSET, NJ – Catalent, Inc., a leader in enabling the development and supply of better treatments for patients worldwide, today announced a strategic  collaboration with Galapagos NV (Euronext & NASDAQ: GLPG), a biotechnology company with operations in the U.S. and Europe, to support decentralized manufacturing for clinical studies....

Lakewood, COLO. AND SANTA ANA, CALIF., January 14, 2025 – Terumo Blood and Cell Technologies (Terumo BCT), and FUJIFILM Irvine Scientific have announced a strategic collaboration to help accelerate T cell expansion using Fujifilm's PRIME-XV® T Cell Expansion Media on Terumo BCT’s Quantum Flex™ Cell Expansion System. By using systems that work together, this collaboration offers an optimized workflow solution with a ready-to-use process, aimed at reducing the barriers in scaling T cell expansion.